GOID	Ontology Source	GOTerm	GOLevels	GOGroups	Nr. Genes	% Associated Genes	Term PValue	Term PValue Corrected with Bonferroni step down	Group PValue	Group PValue Corrected with Bonferroni step down	Associated Genes Found	All Associated Genes	OverViewTerm
WP:3	WikiPathways_09.11.2015	Transcriptional activation by NRF2	[-1]	[Group2]	2	13.333333	0.020143250937645164	0.8863030412563873	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[AIMP2, PIK3CA]	[AIMP2, CEBPB, EPHB2, GCLC, GCLM, GSTA2, HMOX1, KEAP1, MAF, MAPK8, NFE2L2, NQO1, PIK3CA, PRKCA, SLC7A11]	FALSE
WP:12	WikiPathways_09.11.2015	Osteoclast Signaling	[-1]	[Group2]	1	6.25	0.21312048940541917	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[AIMP2]	[ACP5, AIMP2, ATP6V1G1, CTSK, GPR68, IFNAR1, IFNB1, ITGB3, MAPK8, PDGFB, SLC9A1, SPP1, TNFRSF11A, TNFRSF11B, TNFSF11, TRPV5]	FALSE
WP:45	WikiPathways_09.11.2015	G1 to S cell cycle control	[-1]	[Group2]	7	10.294118	5.572753856456339E-5	0.00328792477530924	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDC25A, CDK4, CDKN2A, MCM7, RBL1, TP53, WEE1]	[ATF6B, ATM, CCNA1, CCNB1, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNG2, CCNH, CDC25A, CDC45, CDK1, CDK2, CDK4, CDK6, CDK7, CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDKN2B, CDKN2C, CDKN2D, CREB1, CREB3, CREB3L1, CREB3L3, CREB3L4, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, GADD45A, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MDM2, MNAT1, MYC, MYT1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, POLA2, POLE, POLE2, PRIM1, PRIM2, RB1, RBL1, RPA1, RPA2, RPA3, TFDP1, TFDP2, TP53, WEE1]	FALSE
WP:49	WikiPathways_09.11.2015	IL-2 Signaling Pathway	[-1]	[Group2]	2	4.7619047	0.12817190131944495	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, RPS6KB1]	[AKT1, BCL2, CBL, CCND2, CISH, CRKL, FOS, FOXO3, FYN, GAB2, GRB2, HRAS, IL2, IL2RA, IL2RB, IL2RG, JAK1, JAK3, JUN, LCK, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPT, MYC, NMI, PIK3R1, PTK2B, PTPN11, RAF1, RPS6, RPS6KB1, RPS6KB2, SHC1, SOCS3, SOS1, STAT1, STAT3, STAT5A, STAT5B, SYK]	FALSE
WP:53	WikiPathways_09.11.2015	ID signaling pathway	[-1]	[Group13]	1	6.25	0.21312048940541917	1.0	{Group13=0.21312048940541917}	{Group13=1.0}	[RBL1]	[CCNE1, CDK2, ELK1, ELK3, ELK4, ID1, ID2, ID3, MYOD1, PAX2, PAX5, PAX8, RB1, RBL1, RBL2, SREBF1]	TRUE
WP:78	WikiPathways_09.11.2015	TCA Cycle	[-1]	[Group18]	1	5.882353	0.2248406641564533	1.0	{Group18=0.3126087770842311}	{Group18=0.3126087770842311}	[FH]	[ACO2, CS, DLD, DLST, FH, IDH2, IDH3A, IDH3B, IDH3G, MDH2, OGDH, SDHA, SDHB, SDHC, SDHD, SUCLG1, SUCLG2]	FALSE
WP:100	WikiPathways_09.11.2015	Glutathione metabolism	[-1]	[Group0]	1	4.1666665	0.3021981401384619	0.3021981401384619	{Group0=0.3021981401384619}	{Group0=0.6043962802769238}	[GPX4]	[ANPEP, G6PD, GCLC, GCLM, GGT1, GGT2, GGT5, GGTLC1, GGTLC2, GPX1, GPX2, GPX3, GPX4, GSR, GSS, GSTA1, GSTA5, GSTM1, GSTM2, GSTT2, GSTT2B, IDH1, LOC102724197, OPLAH]	TRUE
WP:179	WikiPathways_09.11.2015	Cell Cycle	[-1]	[Group2]	12	11.650485	2.3484509886909343E-8	1.4795241228752887E-6	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[ATR, CDC25A, CDC25C, CDC6, CDK4, CDKN2A, HDAC2, MCM7, PRKDC, RBL1, TP53, WEE1]	[ABL1, APC, ARF1, ATM, ATR, BUB1, BUB1B, BUB3, CCNA1, CCNA2, CCNB1, CCNB2, CCNB3, CCND2, CCND3, CCNE1, CCNE2, CCNH, CDC14A, CDC14B, CDC20, CDC25A, CDC25B, CDC25C, CDC45, CDC6, CDC7, CDH1, CDK1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CHEK1, CHEK2, DBF4, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, EP300, ESPL1, GADD45A, GSK3B, HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, KITLG, MAD1L1, MAD2L1, MAD2L2, MCM10, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MCM8, MCM9, MDM2, MEN1, MPEG1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, PKMYT1, PLK1, PRKDC, PTTG1, PTTG2, PTTG3P, RB1, RBL1, SKP2, SMAD3, SMAD4, SMC1A, TBC1D8, TFDP1, TGFB1, TP53, UBE2F, WEE1, YWHAB, YWHAE, YWHAG, YWHAH, YWHAQ, YWHAZ]	TRUE
WP:183	WikiPathways_09.11.2015	Proteasome Degradation	[-1]	[Group1]	3	4.83871	0.06371014896807105	1.0	{Group1=0.06371014896807105}	{Group1=0.7008116386487815}	[PSMB10, PSMC5, UBC]	[H2AFX, H2AFZ, HIST1H2AB, HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, IFNG, NEDD4, PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMB1, PSMB10, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD1, PSMD10, PSMD11, PSMD12, PSMD13, PSMD2, PSMD3, PSMD4, PSMD5, PSMD6, PSMD7, PSMD8, PSMD9, PSME1, PSME2, PSME3, RPN1, RPN2, UBA1, UBA7, UBB, UBC, UBE2B, UBE2D1, UBE2D2, UBE2D3, UCHL1, UCHL3]	TRUE
WP:186	WikiPathways_09.11.2015	Homologous recombination	[-1]	[Group2]	1	7.6923075	0.17690141394072634	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[RAD52]	[ATM, BRCA2, MRE11A, NBN, POLD1, POLD2, POLD3, POLD4, RAD50, RAD51, RAD52, RAD54B, RPA1]	FALSE
WP:206	WikiPathways_09.11.2015	Fatty Acid Omega Oxidation	[-1]	[Group4]	2	12.5	0.022802371368705818	0.9805019688543501	{Group4=0.0018530379237337033}	{Group4=0.02779556885600555}	[ADH1A, CYP2D6]	[ADH1A, ADH1B, ADH1C, ADH4, ADH6, ADH7, ALDH1A1, ALDH2, CYP1A1, CYP1A2, CYP2A6, CYP2D6, CYP2E1, CYP3A4, CYP4A11, CYP4A22]	FALSE
WP:231	WikiPathways_09.11.2015	TNF alpha Signaling Pathway	[-1]	[Group2]	4	4.347826	0.04693046760321242	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, MAP3K1, MAP3K5, RIPK1]	[AKT1, APAF1, BAD, BAX, BCL2L1, BID, BIRC2, BIRC3, BTRC, CASP3, CASP7, CASP8, CASP9, CCL2, CDC37, CFLAR, CHUK, CREBBP, CSNK2A1, CUL1, CYBA, DIABLO, FADD, FBXW11, GLUL, GRB2, HRAS, HSP90AA1, IKBKB, IKBKG, IL6, JUN, KRAS, KSR1, KSR2, MADD, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K14, MAP3K3, MAP3K5, MAP3K7, MAP3K8, MAP4K2, MAPK1, MAPK3, MAPK8, MAPK9, NFKB1, NFKB2, NFKBIA, NFKBIB, NFKBIE, NOX1, NOXO1, NRAS, NSMAF, OTUD7B, PLK1, PPP2CA, PRKCZ, PSMD2, PTPRCAP, PYGL, RAC1, RAF1, REL, RFFL, RFK, RIPK1, RIPK3, SELE, SKP1, SMPD2, SOS1, TAB1, TAB2, TAB3, TANK, TBK1, TNF, TNFAIP3, TNFRSF1A, TNFRSF1B, TRADD, TRAF1, TRAF2, TRAP1, TXN]	FALSE
WP:254	WikiPathways_09.11.2015	Apoptosis	[-1]	[Group2]	4	4.7619047	0.0353721344562372	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDKN2A, MAP3K1, RIPK1, TP53]	[AKT1, APAF1, BAD, BAK1, BAX, BBC3, BCL2, BCL2L1, BCL2L11, BCL2L2, BID, BIRC2, BIRC3, BIRC5, BNIP3L, BOK, CASP1, CASP10, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, CASP9, CDKN2A, CFLAR, CHUK, CRADD, CYCS, DFFA, DFFB, DIABLO, FADD, FAS, FASLG, GZMB, HELLS, HRK, IGF1, IGF1R, IGF2, IKBKB, IKBKG, IRF1, IRF2, IRF3, IRF4, IRF5, IRF6, IRF7, JUN, LTA, MAP2K4, MAP3K1, MAPK10, MCL1, MDM2, MYC, NFKB1, NFKBIA, NFKBIB, NFKBIE, PIK3R1, PMAIP1, PRF1, RELA, RIPK1, SCAF11, TNF, TNFRSF10B, TNFRSF1A, TNFRSF1B, TNFRSF21, TNFRSF25, TNFSF10, TP53, TP63, TP73, TRADD, TRAF1, TRAF2, TRAF3, XIAP]	FALSE
WP:299	WikiPathways_09.11.2015	Nuclear Receptors in Lipid Metabolism and Toxicity	[-1]	[Group4]	2	5.5555553	0.09915237676962549	1.0	{Group4=0.0018530379237337033}	{Group4=0.02779556885600555}	[ABCB1, CYP2C9]	[ABCA1, ABCB1, ABCB11, ABCB4, ABCC2, ABCC3, ABCD2, ABCD3, ABCG1, ABCG5, CYP1A2, CYP24A1, CYP26A1, CYP27B1, CYP2B6, CYP2C9, CYP2E1, CYP3A4, CYP4A11, CYP4A22, CYP4B1, CYP7A1, CYP8B1, MIR33A, MIR33B, NR1H3, NR1H4, NR1I2, NR1I3, PPARA, PPARD, PPARG, RARA, RARB, RARG, VDR]	FALSE
WP:304	WikiPathways_09.11.2015	Kit receptor signaling pathway	[-1]	[Group2]	3	5.084746	0.056491055153262706	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, KIT, RPS6KB1]	[AKT1, BAD, BCL2, BTK, CBL, CRK, CRKL, DOK1, EP300, FOS, FOXO3, FYN, GAB2, GRB10, GRB2, GRB7, HRAS, INPP5D, JAK2, JUNB, KIT, KITLG, LYN, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MAPT, MATK, MITF, PIK3R1, PIK3R2, PLCG1, PRKCA, PRKCB, PTPN11, PTPN6, RAF1, RPS6, RPS6KA1, RPS6KA3, RPS6KB1, SH2B2, SHC1, SNAI1, SNAI2, SOCS1, SOCS6, SOS1, SRC, STAT1, STAT3, STAT5A, STAT5B, TBX2, TEC, VAV1]	FALSE
WP:313	WikiPathways_09.11.2015	Signaling of Hepatocyte Growth Factor Receptor	[-1]	[Group2]	2	5.882353	0.08995440515174646	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, PIK3CA]	[CRK, CRKL, DOCK1, ELK1, FOS, GAB1, GRB2, HGF, HRAS, ITGA1, ITGB1, JUN, MAP2K1, MAP2K2, MAP4K1, MAPK1, MAPK3, MAPK8, MET, PAK1, PIK3CA, PTEN, PTK2, PTK2B, PTPN11, PXN, RAF1, RAP1A, RAP1B, RAPGEF1, RASA1, SOS1, SRC, STAT3]	FALSE
WP:314	WikiPathways_09.11.2015	FAS pathway and Stress induction of HSP regulation	[-1]	[Group9]	3	7.142857	0.023817176106831543	1.0	{Group9=0.023817176106831543}	{Group9=0.2858061132819785}	[MAP3K1, PARP1, PRKDC]	[ACTA1, ACTB, ACTG1, APAF1, ARHGDIB, BCL2, CASP10, CASP3, CASP6, CASP7, CASP8, CASP9, CFLAR, CYCS, DAXX, DFFA, DFFB, FADD, FAF1, FAS, FASLG, HSPB1, IL1A, JUN, LMNA, LMNB1, LMNB2, MAP2K4, MAP3K1, MAP3K7, MAPK8, MAPKAPK2, MAPKAPK3, NFX1, PAK1, PAK2, PARP1, PRKDC, RB1, RIPK2, SPTAN1, TNF]	TRUE
WP:322	WikiPathways_09.11.2015	Osteoblast Signaling	[-1]	[Group2]	1	7.142857	0.18915344995357675	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[PDGFRB]	[BGLAP, COL1A1, FGF23, IBSP, ITGAV, ITGB3, PDGFB, PDGFRA, PDGFRB, PTH, PTH1R, SLC17A2, TNFRSF11B, TNFSF11]	FALSE
WP:325	WikiPathways_09.11.2015	Triacylglyceride Synthesis	[-1]	[Group10]	1	4.1666665	0.3021981401384619	0.3021981401384619	{Group10=0.3021981401384619}	{Group10=0.6043962802769238}	[AGPAT2]	[AGPAT1, AGPAT2, AGPAT3, AGPAT4, AGPAT5, AGPS, DGAT1, DGAT2, GK, GK2, GNPAT, GPAM, GPD1, LIPC, LIPE, LIPF, LPL, MOGAT1, MOGAT2, MOGAT3, PLPP1, PLPP2, PLPP3, PNPLA2]	TRUE
WP:384	WikiPathways_09.11.2015	Apoptosis Modulation by HSP70	[-1]	[Group2]	2	10.526316	0.03157899813314309	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[MAP3K1, RIPK1]	[AIFM1, APAF1, BID, CASP2, CASP3, CASP6, CASP7, CASP8, CASP9, CYCS, FADD, FAS, FASLG, HSPA1A, MAP3K1, MAPK10, NFKB1, RIPK1, TNFRSF1A]	FALSE
WP:400	WikiPathways_09.11.2015	p38 MAPK Signaling Pathway	[-1]	[Group2]	4	11.764706	0.0014790862009174005	0.08134974105045703	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, MAP3K1, MAP3K5, RIPK1]	[ATF2, CDC42, CREB1, DAXX, DDIT3, ELK1, GRB2, HMGN1, HRAS, HSPB1, MAP2K4, MAP2K6, MAP3K1, MAP3K5, MAP3K7, MAP3K9, MAPK14, MAPKAPK2, MAPKAPK5, MAX, MEF2D, MKNK1, MYC, PLA2G4A, RAC1, RASGRF1, RIPK1, RPS6KA5, SHC1, STAT1, TGFB2, TGFBR1, TRADD, TRAF2]	FALSE
WP:410	WikiPathways_09.11.2015	Diurnally Regulated Genes with Circadian Orthologs	[-1]	[Group17]	2	4.1666665	0.15889309201568572	1.0	{Group17=0.10896758103203823}	{Group17=1.0}	[EIF4G2, PPP2CB]	[ARNTL, AZIN1, BTG1, CBX3, CEBPB, CLDN5, CLOCK, CRY1, CRY2, DAZAP2, DNAJA1, EIF4G2, ERC2, ETV6, G0S2, GFRA1, GSTM3, GSTP1, HERPUD1, HIST1H2BN, HLA-DMA, HSPA8, IDI1, KLF9, MYF6, NCKAP1, NCOA4, NR1D2, PER1, PER2, PIGF, PPP1R3C, PPP2CB, PSMA4, PURA, QKI, RBPMS, SF3A3, STBD1, SUMO1, SUMO3, TAB2, TOB1, TUBB3, UCP3, UGP2, VAPA, ZFR]	FALSE
WP:422	WikiPathways_09.11.2015	MAPK Cascade	[-1]	[Group2]	2	6.8965516	0.06822024362478778	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, MAP3K1]	[ARAF, BRAF, ELK1, HRAS, JUN, KRAS, MAP2, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K12, MAP3K2, MAP3K3, MAPK1, MAPK10, MAPK12, MAPK14, MAPK3, MBP, NRAS, PLCB3, RAF1, RASA3, RRAS, SIPA1]	FALSE
WP:438	WikiPathways_09.11.2015	Non-homologous end joining	[-1]	[Group11]	2	28.571428	0.004349680618752622	0.22618339217513633	{Group11=0.004349680618752622}	{Group11=0.06089552866253671}	[PRKDC, XRCC4]	[MRE11A, NHEJ1, PRKDC, RAD50, XRCC4, XRCC5, XRCC6]	TRUE
WP:466	WikiPathways_09.11.2015	DNA Replication	[-1]	[Group12]	3	7.142857	0.023817176106831543	1.0	{Group12=0.023817176106831543}	{Group12=0.2858061132819785}	[CDC6, MCM7, UBC]	[CDC45, CDC6, CDC7, CDK2, CDT1, DBF4, GMNN, MCM10, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, POLA1, POLA2, POLD1, POLD2, POLD3, POLD4, POLE, POLE2, PRIM1, PRIM2, RFC1, RFC2, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3, RPA4, UBA52, UBC]	TRUE
WP:500	WikiPathways_09.11.2015	Glycogen Metabolism	[-1]	[Group17]	2	5.5555553	0.09915237676962549	1.0	{Group17=0.10896758103203823}	{Group17=1.0}	[PPP2CB, PPP2R4]	[AGL, CALM1, CALM2, CALM3, GBE1, GSK3A, GSK3B, GYG1, GYG2, GYS1, GYS2, PGM1, PHKA1, PHKA2, PHKB, PHKG1, PHKG2, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R2A, PPP2R2B, PPP2R2C, PPP2R3A, PPP2R3B, PPP2R4, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E, PYGB, PYGL, PYGM, UGP2]	FALSE
WP:524	WikiPathways_09.11.2015	G13 Signaling Pathway	[-1]	[Group2]	2	5.1282053	0.11341541964978193	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[PIK3CA, RPS6KB1]	[ARHGDIB, ARHGDIG, ARHGEF1, CALM1, CDC42, CFL1, CFL2, CIT, CYFIP1, DIAPH1, GNA13, IQGAP1, IQGAP2, LIMK1, LOC100505585, MAP3K4, MAPK10, MYBPH, MYL1, PAK3, PFN1, PIK3CA, PIK3CB, PIK3CD, PIK3R2, PIP4K2A, PKN1, PPP1CB, RAC1, RHOA, RHPN2, ROCK1, ROCK2, RPS6KB1, RTKN, SH3RF1, TNK2, WAS, WASL]	FALSE
WP:531	WikiPathways_09.11.2015	Mismatch repair	[-1]	[Group14]	1	11.111111	0.12604106462134024	1.0	{Group14=0.12604106462134024}	{Group14=1.0}	[LIG1]	[EXO1, LIG1, MLH1, MSH2, MSH6, PCNA, POLD1, RFC1, RPA1]	TRUE
WP:545	WikiPathways_09.11.2015	Complement Activation	[-1]	[Group15]	1	4.5454545	0.2809082343298341	0.8427247029895022	{Group15=0.2809082343298341}	{Group15=0.8427247029895022}	[C8A]	[C1QA, C1QB, C1QC, C1R, C1S, C2, C3, C4A, C4B, C5, C6, C7, C8A, C8B, C8G, C9, CD55, CFB, CFD, CFP, MASP1, MASP2]	TRUE
WP:554	WikiPathways_09.11.2015	ACE Inhibitor Pathway	[-1]	[Group16]	1	5.882353	0.2248406641564533	1.0	{Group16=0.2248406641564533}	{Group16=1.0}	[ACE2]	[ACE, ACE2, AGT, AGTR1, AGTR2, ATP6AP2, BDKRB1, BDKRB2, CMA1, CTSG, CYP11B2, KNG1, MAS1, NOS3, NR3C2, REN, TGFB1]	TRUE
WP:673	WikiPathways_09.11.2015	ErbB Signaling Pathway	[-1]	[Group2]	4	7.2727275	0.008608788411466934	0.42183063216187977	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[EGFR, HRAS, RPS6KB1, TP53]	[ABL1, AKT3, ARAF, AREG, BAD, BCL2L11, BTC, CAMK2A, CBLC, CCND1, CDKN1A, CDKN1B, CRK, EGF, EGFR, EIF4EBP1, ELK1, ERBB2, ERBB3, ERBB4, EREG, FOXO1, GAB1, GRB2, GSK3B, HBEGF, HRAS, JUN, KRAS, MAP2K1, MAP2K7, MAPK1, MAPK8, MDM2, MIR21, MTOR, MYC, NCK1, NRG1, NRG2, NRG3, NRG4, PAK4, PDK1, PIK3R5, PLCG1, PRKCA, PTK2, RPS6KB1, SHC2, SOS1, SRC, STAT5A, TGFA, TP53]	FALSE
WP:678	WikiPathways_09.11.2015	Arachidonate Epoxygenase / Epoxide Hydrolase	[-1]	[Group4]	1	14.285714	0.09946108338025017	1.0	{Group4=0.0018530379237337033}	{Group4=0.02779556885600555}	[CYP2C9]	[COX5A, COX8A, CYP2C8, CYP2C9, CYP2J2, EPHX2, GSTP1]	FALSE
WP:691	WikiPathways_09.11.2015	Tamoxifen metabolism	[-1]	[Group4]	2	9.523809	0.03805227298926039	1.0	{Group4=0.0018530379237337033}	{Group4=0.02779556885600555}	[CYP2C9, CYP2D6]	[CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, FMO1, FMO3, SULT1A1, SULT1E1, SULT2A1, UGT1A10, UGT1A4, UGT1A8, UGT2B15, UGT2B7]	FALSE
WP:707	WikiPathways_09.11.2015	DNA Damage Response	[-1]	[Group2]	7	10.294118	5.572753856456339E-5	0.00328792477530924	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[ATR, CDC25A, CDC25C, CDK4, PRKDC, RAD52, TP53]	[ABL1, APAF1, ATM, ATR, ATRIP, BAX, BBC3, BID, BRCA1, CASP3, CASP8, CASP9, CCNB1, CCNB2, CCNB3, CCND1, CCND2, CCND3, CCNE1, CCNE2, CDC25A, CDC25C, CDK1, CDK2, CDK4, CDK5, CDK6, CDKN1A, CDKN1B, CHEK1, CHEK2, CREB1, CYCS, DDB2, E2F1, FANCD2, FAS, GADD45A, GADD45B, GADD45G, H2AFX, HUS1B, MDM2, MRE11A, MYC, NBN, PIDD1, PMAIP1, PML, PRKDC, RAD1, RAD17, RAD50, RAD51, RAD52, RAD9A, RB1, RFC1, RPA2, RRM2B, SESN1, SFN, SMC1A, TLK1, TLK2, TNFRSF10B, TP53, TP53AIP1]	FALSE
WP:710	WikiPathways_09.11.2015	DNA Damage Response (only ATM dependent)	[-1]	[Group2]	5	4.5045047	0.023817848845443565	0.9765318026631862	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDKN2A, HRAS, MAP3K1, PIK3CA, TP53]	[ABL1, AKT1, AKT2, AKT3, APC, ATM, AXIN1, BAD, BAK1, BAX, BBC3, BCL2, BCL2L11, BCL6, BIK, CAT, CCND1, CCND2, CCND3, CCNG2, CDC42, CDKN1A, CDKN1B, CDKN2A, CTNNB1, DVL1, DVL2, DVL3, ERBB2, FASLG, FOSL1, FOXO3, FRAT1, G6PC, GRB2, GSK3B, HMGB1, HRAS, INSR, IRS1, JUN, KRAS, LDLR, LEF1, LOC100129518, LOC101929777, MAP3K1, MAP3K4, MAP3K7, MAPK1, MAPK10, MAPK8, MAPK9, MDM2, MLKL, MYC, NFKB1, NFKB2, NRAS, PCK2, PDK1, PIK3C2A, PIK3C2B, PIK3C2G, PIK3C3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R4, PLAU, PMAIP1, PPP2R5C, PPP2R5E, PTEN, RAC1, RAC2, RAC3, RBL2, RHOA, SCP2, SHC1, SMAD3, SMAD4, SOD2, SOS1, SOS2, TCF7, TCF7L1, TCF7L2, TGFB1, TP53, TP73, WNT1, WNT10A, WNT10B, WNT11, WNT16, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B]	FALSE
WP:712	WikiPathways_09.11.2015	Estrogen signaling pathway	[-1]	[Group2]	1	4.347826	0.2916320551982414	0.5832641103964828	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[PIK3CA]	[AKT1, BCL2, BRAF, CHUK, CREB1, ELK1, ESR1, FOS, GNAS, GNB1, GNGT1, GPER1, IKBKB, IKBKG, JUN, MAP2K1, MAPK1, MAPK14, MAPK9, NFKB1, PIK3CA, PRKACA, SP1]	FALSE
WP:727	WikiPathways_09.11.2015	Monoamine Transport	[-1]	[Group17]	2	6.25	0.08103222486947534	1.0	{Group17=0.10896758103203823}	{Group17=1.0}	[CDC25C, PPP2CB]	[ACHE, ADORA2A, AGT, AMPH, CDC25C, DBH, FBXO32, HRH3, IL1B, IL1R1, ITGB3, MAPK14, NOS1, PPP2CB, PVRL2, RBL2, SCAMP2, SLC5A7, SLC6A1, SLC6A2, SLC6A3, SLC6A4, STX1A, SYN1, TDO2, TGFB1I1, TH, TNF, TNFRSF11B, TPH2, TSC2, UNC13B]	FALSE
WP:732	WikiPathways_09.11.2015	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	[-1]	[Group2]	1	5.0	0.2589780667513447	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS]	[ELK1, ELK4, GATA4, GNAQ, HRAS, HTR2A, HTR2B, HTR2C, ITPR1, KRAS, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPKAPK2, NRAS, RAF1, RASGRF1, RASGRP1, SRF]	FALSE
WP:1403	WikiPathways_09.11.2015	AMPK Signaling	[-1]	[Group2]	3	4.347826	0.08211224424331526	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[PIK3CA, RPS6KB1, TP53]	[ACACA, ACACB, ADIPOQ, ADIPOR1, ADIPOR2, ADRA1A, ADRA1B, AKT1, AKT2, CAB39, CAMKK1, CAMKK2, CCNA1, CCNA2, CCNB1, CDKN1A, CPT1A, CPT1B, CPT1C, CRTC2, EEF2, EEF2K, EIF4EBP1, ELAVL1, FASN, GYS1, GYS2, HMGCR, HNF4A, INS-IGF2, INSR, LEP, LEPR, LIPE, LOC101930123, MEF2BNB-MEF2B, MTOR, PFKFB3, PIK3C3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PLCB1, PPARGC1B, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKACB, PRKACG, PRKAG1, PRKAG2, PRKAG3, RPS6KB1, RPS6KB2, RPTOR, SLC2A4, SLC2A4RG, SREBF1, STK11, STRADA, STRADB, TP53, TSC1, TSC2]	FALSE
WP:1455	WikiPathways_09.11.2015	Serotonin Transporter Activity	[-1]	[Group17]	1	9.090909	0.15184709905906266	1.0	{Group17=0.10896758103203823}	{Group17=1.0}	[PPP2CB]	[IL1B, IL1R1, ITGB3, MAOA, NOS1, PPP2CB, SCAMP2, SLC6A4, STX1A, TGFB1I1, TPH2]	TRUE
WP:1530	WikiPathways_09.11.2015	miRNA Regulation of DNA Damage Response	[-1]	[Group2]	8	9.302325	3.343078078004941E-5	0.002039277627583014	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[ATR, CDC25A, CDC25C, CDK4, MCM7, PRKDC, RAD52, TP53]	[ABL1, APAF1, ATM, ATR, ATRIP, BAX, BBC3, BID, BRCA1, CASP3, CASP8, CASP9, CCNB1, CCNB2, CCNB3, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNG1, CDC20B, CDC25A, CDC25C, CDK1, CDK2, CDK4, CDK5, CDK6, CDKN1A, CDKN1B, CHEK1, CHEK2, CREB1, CYCS, DDB2, E2F1, FANCD2, FAS, GADD45A, GADD45B, GADD45G, H2AFX, HUS1B, MCM7, MDM2, MIR106B, MIR16-1, MIR17HG, MIR181A1, MIR203A, MIR21, MIR210, MIR221, MIR222, MIR223, MIR3074, MIR330, MIR373, MIR449A, MIR449B, MRE11A, MYC, NBN, PIDD1, PMAIP1, PML, PRKDC, RAD1, RAD17, RAD50, RAD51, RAD52, RAD9A, RB1, RFC1, RPA2, RRM2B, SESN1, SFN, SMC1A, TLK1, TLK2, TNFRSF10B, TP53, TP53AIP1]	FALSE
WP:1539	WikiPathways_09.11.2015	Angiogenesis	[-1]	[Group2]	1	4.1666665	0.3021981401384619	0.3021981401384619	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[PIK3CA]	[AKT1, ANGPT1, ARNT, CREBBP, FGF2, FGFR2, FLT1, HIF1A, KDR, MAPK1, MAPK14, MMP9, NOS3, PDGFB, PDGFRA, PIK3CA, PLCG1, PTK2, SMAD1, SRC, TEK, TIMP2, TIMP3, VEGFA]	FALSE
WP:1545	WikiPathways_09.11.2015	miRNAs involved in DNA damage response	[-1]	[Group2]	3	6.976744	0.025336483670349436	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDC25A, RAD52, TP53]	[ABL1, ATM, CCND1, CCND3, CCNE1, CDC25A, CDK6, CDKN1A, CDKN1B, CREB1, E2F1, H2AFX, MIR100, MIR106B, MIR143, MIR15B, MIR16-1, MIR181A1, MIR181B1, MIR203A, MIR21, MIR210, MIR221, MIR222, MIR223, MIR23A, MIR23B, MIR25, MIR27A, MIR3074, MIR330, MIR371A, MIR372, MIR373, MIR449A, MIR449B, MIR449C, MIR503, MIR93, MIRLET7B, MYC, RAD52, TP53]	FALSE
WP:1601	WikiPathways_09.11.2015	Fluoropyrimidine Activity	[-1]	[Group2, Group4]	2	6.060606	0.08545733002768117	1.0	{Group2=3.192846690077313E-6, Group4=0.0018530379237337033}	{Group2=5.427839373131432E-5, Group4=0.02779556885600555}	[ABCC4, TP53]	[ABCC3, ABCC4, ABCC5, ABCG2, CDA, CES1, CES2, CYP2A6, DHFR, DPYD, DPYS, ERCC2, FPGS, GGH, MTHFR, PPAT, RRM1, RRM2, SLC22A7, SLC29A1, SMUG1, TDG, TK1, TP53, TYMP, TYMS, UCK1, UCK2, UMPS, UPB1, UPP1, UPP2, XRCC3]	FALSE
WP:1604	WikiPathways_09.11.2015	Codeine and Morphine Metabolism	[-1]	[Group4]	2	25.0	0.0057440455982835925	0.2872022799141796	{Group4=0.0018530379237337033}	{Group4=0.02779556885600555}	[ABCB1, CYP2D6]	[ABCB1, ABCC2, ABCC3, CYP2D6, CYP3A4, SLCO1B1, UGT1A1, UGT2B7]	TRUE
WP:1742	WikiPathways_09.11.2015	TP53 Network	[-1]	[Group2]	2	10.526316	0.03157899813314309	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDKN2A, TP53]	[ABL1, ATM, BAX, BBC3, BCL2, BID, BOK, CDKN1A, CDKN2A, GADD45A, MDM2, MYC, OTX2, PMAIP1, SUMO1, TNFSF10, TP53, TP63, TP73]	FALSE
WP:1772	WikiPathways_09.11.2015	Apoptosis Modulation and Signaling	[-1]	[Group2]	4	4.4444447	0.04386494149295503	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDKN2A, MAP3K5, RIPK1, TP53]	[AIFM1, AIFM2, APAF1, BAD, BAG3, BAK1, BAX, BBC3, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L11, BCL2L2, BID, BIK, BIRC2, BIRC3, BIRC5, BIRC6, BIRC7, BLK, BMF, BOK, CAPNS1, CASP1, CASP10, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, CASP9, CDKN2A, CFLAR, CRADD, CYCS, DAXX, DFFA, DFFB, DIABLO, ENDOG, FADD, FAS, FASLG, FOS, HN1, HRK, HSPA1A, HTRA2, IKBKB, IL1R1, IL1R2, IRAK1, JUN, MADD, MAP3K14, MAP3K5, MAPK3, MAPK8, MCL1, MYD88, NAIP, NFKB1, NFKBIA, PEA15, PIDD1, PMAIP1, PRKD1, PTPN13, PTRH2, RIPK1, SEPT4, TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFRSF11B, TNFRSF1A, TNFRSF1B, TNFRSF25, TNFRSF6B, TNFSF10, TOLLIP, TP53, TRADD, TRAF3, TRAF6, XIAP]	FALSE
WP:1971	WikiPathways_09.11.2015	Integrated Cancer pathway	[-1]	[Group2]	5	10.869565	5.351962903531571E-4	0.0299709922597768	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[ATR, CDC25A, CDK4, MAP3K5, TP53]	[AKT1, ATF1, ATM, ATR, BACH1, BAD, BARD1, BAX, BBC3, BCL2, BLM, BRCA1, CASP3, CASP8, CASP9, CDC25A, CDC25B, CDK1, CDK2, CDK4, CDKN1A, CDKN1B, CDKN2B, CHEK1, CHEK2, E2F1, GRIK1-AS2, JAK1, MAP3K5, MDM2, MIR21, MMP1, MRE11A, MSH2, MSH6, MYC, NOXA1, PLK1, POU2F1, PTEN, RAD50, RB1, SMAD2, SMAD3, STAT1, TP53]	FALSE
WP:1984	WikiPathways_09.11.2015	Integrated Breast Cancer Pathway	[-1]	[Group2]	8	5.263158	0.0016903499234243438	0.09127889586491457	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[ATR, CDC25A, CDK4, DAG1, EGFR, PLK3, TP53, WEE1]	[ABL1, AHR, AKT1, ALKBH1, ANXA1, APOBEC3G, AR, ARAF, ATF1, ATM, ATR, AURKA, BACH1, BAD, BAK1, BARD1, BAX, BCL2, BID, BLM, BMPR1A, BMPR2, BRAF, BRCA1, BRCA2, CASP3, CASP8, CASP9, CCNB1IP1, CCND1, CDC25A, CDC25B, CDC42, CDH1, CDK2, CDK4, CDK7, CERK, CHEK1, CHEK2, CHUK, CREB1, CSNK1D, CTNNB1, CYP19A1, DAG1, DCAKD, DHTKD1, E2F1, EDAR, EGFR, EP300, ERAL1, ESR1, FADD, FAU, FER, FILIP1, FOSL1, FOXO1, GADD45A, GDI1, GRIK1-AS2, GRN, GSK3A, HDAC1, HIPK2, HMGCR, IMPA1, IRS1, ITPKC, JAK1, JAKMIP1, JUN, KRAS, LGALS13, MAP3K13, MAP3K7CL, MAPK1, MAX, MDM2, MIR21, MMP1, MRE11A, MSH2, MSH6, MTOR, MYC, MYCBP2, MYT1, NAB1, NCOA3, NF1, NFKB1, NOXA1, NUP85, ODC1, PAK1, PHB, PIAS1, PIGR, PIK3R2, PKIA, PLK1, PLK3, PML, PPP4R3A, PTEN, RAC1, RAD50, RAD51, RAD54L, RALA, RALGAPA1, RAP1A, RASGEF1A, RASGRP3, RB1, RHEB, RHO, RPP38, RRAS, SIRT1, SMAD1, SMAD2, SMAD4, SMAD6, SMAD7, SMARCA4, SP1, STAT1, STK11, TAB1, TFPI, TGFBR1, TGFBR2, TP53, TPR, TRADD, TSC1, TSC2, UBE2F, USP15, USP16, USP21, USP38, VEGFA, WEE1, XRCC3, ZMIZ1, ZMYND8, ZNF655]	FALSE
WP:2011	WikiPathways_09.11.2015	SREBF and miR33 in cholesterol and lipid homeostasis	[-1]	[Group3]	1	5.5555553	0.2363886617149547	1.0	{Group3=0.2363886617149547}	{Group3=0.9455546468598188}	[SREBF2]	[ABCA1, FASN, HMGCR, HMGCS1, LDLR, MED15, MIR33A, MIR33B, MTOR, NR1H3, PPARA, PPARGC1A, PRKAA1, SCD, SIRT1, SIRT6, SREBF1, SREBF2]	TRUE
WP:2032	WikiPathways_09.11.2015	TSH signaling pathway	[-1]	[Group2]	4	6.060606	0.016106467319205318	0.7408974966834446	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDK4, HRAS, PIK3CA, RPS6KB1]	[ADCY2, ADCY3, AKT1, APEX1, BRAF, CCND3, CCNE1, CDK2, CDK4, CDKN1B, CGA, CREB1, E2F1, EGR1, FOS, GNA12, GNA13, GNAI1, GNAI2, GNAI3, GNAO1, GNAQ, GNAS, GNB1, GNG2, HRAS, IGF1R, JAK1, JAK2, JUN, KCNIP3, MAP2K1, MAP2K3, MAP2K6, MAPK1, MAPK14, MAPK3, MTOR, MYC, MYL12B, PAX8, PDE4D, PDPK1, PIK3CA, PIK3R1, PIK3R2, PLCB1, PLD1, RAF1, RALGDS, RAP1A, RAP1B, RAP1GAP, RB1, RBL2, RPS6, RPS6KA1, RPS6KB1, SCRIB, SRC, STAT1, STAT3, TSHB, TSHR, TTF1, TTF2]	FALSE
WP:2034	WikiPathways_09.11.2015	Leptin signaling pathway	[-1]	[Group2]	3	4.0	0.09950368281495928	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, KHDRBS1, RPS6KB1]	[ACACA, ACACB, AKT1, BAD, BAX, BCL2L1, CCND1, CDC42, CFL2, CHUK, CISH, CREB1, EIF4E, EIF4EBP1, ELK1, ERBB2, ESR1, FOXO1, FYN, GRB2, GSK3A, GSK3B, HRAS, IKBKB, IKBKG, IL1B, IL1RN, IRS1, JAK1, JAK2, KHDRBS1, KPNA4, LEP, LEPR, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MTOR, NCOA1, NFKB1, NOS3, PDE3B, PIK3R1, PIK3R2, PLCG1, PLCG2, PRKAA1, PRKAA2, PTK2, PTPN1, PTPN11, RAC1, RAF1, REL, RELA, RHOA, ROCK1, ROCK2, RPS6, RPS6KA1, RPS6KB1, SH2B1, SHC1, SOCS2, SOCS3, SOCS7, SOS1, SP1, SRC, STAT1, STAT3, STAT5B]	FALSE
WP:2249	WikiPathways_09.11.2015	Metastatic brain tumor	[-1]	[Group2]	1	7.142857	0.18915344995357675	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[TP53]	[CDC42, CDK6, E2F3, MIR101-1, MIR148B, MIR29B1, MIR29B2, MIR34A, MIRLET7A2, MIRLET7B, MIRLET7F2, MYC, PIK3R1, TP53]	FALSE
WP:2261	WikiPathways_09.11.2015	Signaling Pathways in Glioblastoma	[-1]	[Group2]	7	8.433735	1.999694981680992E-4	0.011398261395581654	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDK4, CDKN2A, EGFR, HRAS, PDGFRB, PIK3CA, TP53]	[AKT1, AKT2, AKT3, ARAF, ATM, BRAF, BRCA1, BRCA2, CBL, CCND1, CCND2, CCNE1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, E2F1, EGFR, EP300, ERBB2, ERBB3, ERRFI1, FGFR1, FGFR2, FOXO1, FOXO3, FOXO4, GAB1, GRB2, HRAS, IGF1R, IRS1, KRAS, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAPK1, MAPK3, MDM2, MDM4, MET, MIR21, MSH6, NF1, NRAS, PDGFRA, PDGFRB, PDPK1, PIK3C2A, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PLCG1, PLCG2, PRKCA, PRKCB, PRKCD, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PTEN, RAF1, RB1, SPRY2, SRC, TP53, TSC1, TSC2]	FALSE
WP:2289	WikiPathways_09.11.2015	Drug Induction of Bile Acid Pathway	[-1]	[Group2, Group4]	2	11.764706	0.025597693333687593	0.9983100400138161	{Group2=3.192846690077313E-6, Group4=0.0018530379237337033}	{Group2=5.427839373131432E-5, Group4=0.02779556885600555}	[ABCB1, ABCC4]	[ABCB1, ABCB11, ABCC2, ABCC3, ABCC4, BAAT, CYP3A4, CYP7A1, NR1H4, NR1I2, NR1I3, SLC10A1, SLC51A, SLC51B, SLCO1B1, SULT2A1, VDR]	FALSE
WP:2290	WikiPathways_09.11.2015	RalA downstream regulated genes	[-1]	[Group2]	1	8.333333	0.16446685703980682	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS]	[CDC42, EXOC2, EXOC8, HRAS, KRAS, NRAS, RAC1, RAC2, RAC3, RALA, RALBP1, YBX3]	FALSE
WP:2332	WikiPathways_09.11.2015	Interleukin-11 Signaling Pathway	[-1]	[Group2]	3	6.818182	0.02690703173850893	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, PPP2R4, RPS6KB1]	[AKT1, ATF1, BCL2, BGLAP, BIRC5, CHUK, CREB1, FES, FYN, GRB2, HRAS, IBSP, ICAM1, IKBKB, IL11, IL11RA, IL6ST, ITGA2, JAK1, JAK2, MAP2K1, MAP2K2, MAPK1, MAPK3, PDPK1, PIAS1, PIAS3, PIK3R1, PIK3R2, PPP2R4, PTPN11, RAF1, RELA, RPS6, RPS6KA1, RPS6KB1, RUNX2, SOCS3, SRC, STAT1, STAT3, TGFB1, TYK2, YES1]	FALSE
WP:2333	WikiPathways_09.11.2015	Trans-sulfuration pathway	[-1]	[Group5]	1	9.090909	0.15184709905906266	1.0	{Group5=0.15184709905906266}	{Group5=1.0}	[DNMT1]	[AHCY, CBS, CBSL, CSAD, CTH, DNMT1, GCLM, GOT1, MAT2B, MPST, MTR]	TRUE
WP:2363	WikiPathways_09.11.2015	Gastric cancer network 2	[-1]	[Group2]	2	6.451613	0.07668220343902889	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[EGFR, TP53]	[AHCTF1, ATAD2, BRIX1, CACYBP, CD48, CEBPZ, CHTF18, CHTF8, COL9A1, COL9A3, CTNNB1, DSCC1, EGFR, FAM91A1, FANCI, LBR, LMNB2, MTDH, MYC, OTUD5, PLAC8, RAD17, RFC3, RFC4, RNF144B, S100A6, SNURF, TOP2A, TP53, UBE2C, UBE2T]	FALSE
WP:2369	WikiPathways_09.11.2015	Histone Modifications	[-1]	[Group7]	2	4.0816326	0.1641428143837417	1.0	{Group7=0.2290272399979567}	{Group7=1.0}	[EZH2, KMT5B]	[AEBP2, ASH1L, DOT1L, EED, EHMT1, EHMT2, EZH1, EZH2, H3F3A, H3F3B, HIST1H3D, HIST1H3J, HIST1H4C, HIST1H4H, HIST1H4J, HIST2H3A, HIST2H3C, HIST2H3D, HIST4H4, KMT2A, KMT2C, KMT2D, KMT2E, KMT5A, KMT5B, KMT5C, NSD1, PRDM2, SET, SETBP1, SETD1A, SETD1B, SETD2, SETD3, SETD4, SETD5, SETD6, SETD7, SETD9, SETDB1, SETDB2, SETMAR, SMYD1, SMYD2, SMYD3, SMYD4, SMYD5, SUV39H1, SUV39H2]	TRUE
WP:2374	WikiPathways_09.11.2015	Oncostatin M Signaling Pathway	[-1]	[Group2]	3	4.6153846	0.07133617419766919	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, OSMR, TP53]	[AKT1, CASP3, CASP7, CCL2, CDK2, CDKN1B, CEBPB, CREB1, CYR61, EGR1, FOS, GRB2, HIF1A, HRAS, IL6ST, IRS1, JAK1, JAK2, JAK3, JUNB, JUND, KRAS, LDLR, LIFR, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MMP1, MMP13, MMP3, MTOR, NFKB1, NFKBIA, OSM, OSMR, PIAS3, PIK3R1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PTK2B, PTPN11, PXN, RAF1, RELA, RICTOR, RPS6, SERPINE1, SHC1, SOCS3, SOS1, SRC, STAT1, STAT3, STAT5B, TIMP3, TP53, TYK2, VEGFA]	FALSE
WP:2377	WikiPathways_09.11.2015	Integrated Pancreatic Cancer Pathway	[-1]	[Group6]	13	6.7708335	3.5465116839605023E-6	2.1988372440555115E-4	{Group6=3.5465116839605023E-6}	{Group6=5.674418694336804E-5}	[ABCB1, AGPAT2, CDC25C, CDK4, DAG1, EGFR, EZH2, LIG1, MAP3K5, PIK3CA, RAD52, RBL1, TP53]	[ABCB1, ABL1, ACHE, AGPAT2, AKT1, ANXA1, APAF1, APC, APP, AR, ARF1, ATM, BAD, BAX, BBC3, BCL2, BDNF, BID, BLM, BRCA1, BRCA2, BRF1, BUB1B, CAB39, CAMK2A, CAMP, CAPN1, CASP10, CASP12, CASP3, CASP7, CASP8, CASP9, CCNA2, CCND1, CCNE1, CD82, CDC25C, CDK2, CDK4, CDKN1A, CDKN1B, CDKN2B, CHEK1, CHEK2, CHUK, CREB1, CREBBP, CRK, CST3, CTNNB1, DAG1, DAXX, DCC, DFFA, DFFB, E2F1, E2F4, EGF, EGFR, EGR1, EIF2AK2, EP300, ERBB2, ESR1, ESR2, EZH2, FADD, FAS, FASLG, FGF1, FGF2, FGFR1, FKBP1A, FKBP1B, FKBP3, FST, FTL, GADD45A, GPRC5A, GRB2, GSK3A, GTF2A2, HDAC8, HNF4A, HPGDS, HSP90AB1, IAPP, IGF1, IGFBP3, IL11, IL1R1, IL3, INHBA, JUN, JUNB, JUND, KRAS, LEFTY1, LIG1, LTBP1, MAP2K1, MAP3K4, MAP3K5, MAPK1, MAPK14, MAPK3, MAPK4, MAPK7, MAPK8, MAPK9, MAPT, MDM2, MIR21, MNAT1, MRE11A, MST1, MYC, MYT1, NCK1, NFKB1, NFKBIA, NME1, NODAL, NOXA1, NT5C1A, NTF3, NTRK1, PAK1, PCNA, PDGFA, PDGFRA, PDK1, PIAS1, PIK3CA, PITX2, PLA2G4A, PLK1, PLN, PML, POLA1, POLR1A, PPP1R13L, PRKAA2, PRKCA, PTEN, PTGS2, PTTG1, RAC1, RAD50, RAD51, RAD52, RAF1, RAP1A, RAPGEF3, RARA, RARB, RB1CC1, RBL1, RHEB, RRM1, RXRA, SERPINB10, SHH, SIRT1, SMAD2, SMAD4, SMAD6, SMO, SOS1, SP1, SRC, STAT1, STAT5A, STK11, STMN1, TBP, TFF1, TGFB1, TGFBR1, THBS1, TNF, TNFRSF1A, TOP1, TOP2A, TP53, TP53BP2, TRAF2, TYMS, VEGFA, WRN, WT1]	TRUE
WP:2436	WikiPathways_09.11.2015	Dopamine metabolism	[-1]	[Group17]	1	7.6923075	0.17690141394072634	1.0	{Group17=0.10896758103203823}	{Group17=1.0}	[PPP2CB]	[COMT, DDC, MAOA, MAOB, NQO1, PPP2CA, PPP2CB, PRKACA, PRKACB, PRKACG, SOD1, TH, TYR]	FALSE
WP:2446	WikiPathways_09.11.2015	Retinoblastoma (RB) in Cancer	[-1]	[Group2]	8	9.090909	3.9550162477942876E-5	0.0023730097486765727	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDC25A, CDK4, DCK, DNMT1, MCM7, PRKDC, TP53, WEE1]	[ABL1, ANLN, BARD1, CCDC6, CCNA2, CCNB1, CCNB2, CCND1, CCND3, CCNE1, CCNE2, CDC25A, CDC25B, CDC45, CDC7, CDK1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDT1, CHEK1, DCK, DHFR, DNMT1, E2F1, E2F2, E2F3, FAF1, FANCG, H2AFZ, HDAC1, HLTF, HMGB1, HMGB2, KIF4A, MAPK13, MCM3, MCM4, MCM6, MCM7, MDM2, MIR21, MSH6, MYC, NPAT, ORC1, PCNA, PLK4, POLA1, POLD3, POLE, POLE2, PRIM1, PRKDC, PRMT2, RABIF, RAF1, RB1, RBBP4, RBBP7, RBP1, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3, RRM1, RRM2, SAP30, SIN3A, SKP2, SMARCA2, SMC1A, SMC2, SMC3, STMN1, SUV39H1, TFDP1, TFDP2, TOP2A, TP53, TTK, TYMS, WEE1, ZNF655]	FALSE
WP:2447	WikiPathways_09.11.2015	Amyotrophic lateral sclerosis (ALS)	[-1]	[Group2]	2	5.263158	0.10860267556821829	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[MAP3K5, TP53]	[ALS2, APAF1, BAD, BAX, BCL2, BCL2L1, BID, CASP1, CASP12, CASP3, CASP9, CAT, CCS, CST3, DAXX, DERL1, GPX1, GRIA1, MAP2K2, MAP2K6, MAP3K5, MAPK14, NEFH, NEFL, NEFM, NOS1, PPP3CA, PPP3CB, PPP3CC, PRPH, RAB5A, RAC1, SLC1A2, SOD1, TNF, TNFRSF1A, TOMM40, TP53]	FALSE
WP:2453	WikiPathways_09.11.2015	TCA Cycle and PDHc	[-1]	[Group18]	1	6.25	0.21312048940541917	1.0	{Group18=0.3126087770842311}	{Group18=0.3126087770842311}	[FH]	[ACLY, ACO1, CS, DLAT, DLD, DLST, FH, IDH1, IDH3A, MDH1, OGDH, PC, PCK1, PDHA1, SDHA, SUCLG2]	TRUE
WP:2516	WikiPathways_09.11.2015	ATM Signaling Pathway	[-1]	[Group2]	4	10.256411	0.002480755132890141	0.13148002204317746	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDC25A, CDC25C, RIPK1, TP53]	[ABL1, AP3B2, ATF2, ATM, BID, BRCA1, CASP2, CCNB1, CDC25A, CDC25C, CDK1, CDK2, CDKN1A, CHEK1, CHEK2, CRADD, CREB1, FANCD2, GADD45A, H2AFX, IKBKG, JUN, MAPK9, MDC1, MDM2, MDM4, MRE11A, NBN, NFKBIA, PIDD1, RAD50, RAD51, RAD9A, RIPK1, SMC1A, TLK1, TP53, TP53BP1, TP73]	FALSE
WP:2526	WikiPathways_09.11.2015	PDGF Pathway	[-1]	[Group2]	3	7.6923075	0.01956691005075109	0.880510952283799	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[HRAS, MAP3K1, PDGFRB]	[ARFIP2, CDC42, CHUK, COX2, ELK1, FOS, GRB2, HRAS, JAK1, JUN, MAP2K1, MAP2K4, MAP3K1, MAPK1, MAPK3, MAPK8, NFKBIA, PAK1, PDGFA, PDGFB, PDGFRB, PIK3R1, PLA2G4A, PLCG1, PTPN11, RAC1, RAF1, RASA1, RHOA, SHC1, SOS1, SRC, SRF, STAT1, STAT3, TIAM1, VAV1, VAV2, WASL]	FALSE
WP:2586	WikiPathways_09.11.2015	Aryl Hydrocarbon Receptor	[-1]	[Group2]	2	4.347826	0.14849578355355822	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[EGFR, HRAS]	[AHR, AHRR, AIP, ARNT, CCL1, CD36, CDC37, CDK2, CDKN1A, CDKN1B, CYP1A1, CYP1A2, CYP1B1, E2F1, EGFR, EP300, ESR1, FGF21, GCLC, HPGDS, HRAS, HSP90AA1, KLF6, KRAS, LPL, MAP2K1, MAPK1, MYC, NCOA7, NCOR2, NF1, NFE2L2, NFKB1, NQO1, NRAS, NRIP1, PLAGL1, PSRC1, PTGS2, RAF1, RB1, RELA, RET, SRC, TNF, VEGFA]	FALSE
WP:2643	WikiPathways_09.11.2015	Nanoparticle-mediated activation of receptor signaling	[-1]	[Group2]	2	7.142857	0.0641149141198648	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[EGFR, HRAS]	[AKT3, AREG, COL1A1, EGFR, FN1, GRB2, HRAS, ITGA1, ITGB1, KRAS, MAP2K1, MAP2K2, MAPK1, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9, NRAS, PIK3CD, PTK2, PXN, RAF1, SOS1, SRC, TLN1]	FALSE
WP:2828	WikiPathways_09.11.2015	Bladder Cancer	[-1]	[Group2]	5	16.129032	7.885824882435387E-5	0.004573778431812525	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[CDK4, CDKN2A, EGFR, HRAS, TP53]	[BRAF, CCND1, CDH1, CDK4, CDKN1A, CDKN2A, CXCL8, DAPK1, DAPK2, DAPK3, E2F1, EGF, EGFR, ERBB2, FGFR3, HRAS, MAP2K1, MAP2K2, MAPK1, MDM2, MMP1, MYC, PIK3R1, PIK3R2, RASSF1, RB1, RPS6KA5, THBS1, TP53, TYMP, VEGFA]	FALSE
WP:2865	WikiPathways_09.11.2015	IL1 and megakaryotyces in obesity	[-1]	[Group2]	1	4.1666665	0.3021981401384619	0.3021981401384619	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[PIK3CA]	[CCL2, CCR3, F2, F2R, FCER1A, HBEGF, ICAM1, IFNG, IL18, IL1B, IL1R1, IRAK1, MMP9, MYD88, NFKB1, NLRP3, PIK3CA, PLA2G7, S100A9, SELENBP1, TIMP1, TIMP2, TLR1, TLR2]	FALSE
WP:2868	WikiPathways_09.11.2015	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	[-1]	[Group2]	1	20.0	0.0720842805196961	1.0	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[EGFR]	[EGFR, JAK1, MAPK1, MAPK3, STAT3]	FALSE
WP:2870	WikiPathways_09.11.2015	Extracellular vesicle-mediated signaling in recipient cells	[-1]	[Group2]	3	10.0	0.009557290526367388	0.4587499452656346	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[EGFR, HRAS, PROM1]	[AKT1, APC, AXIN1, CTNNB1, DKK4, EGFR, ERBB2, HGF, HRAS, KRAS, MET, MFGE8, MTOR, NRAS, PIK3R5, PROM1, RAF1, SMAD2, SMAD3, SMAD4, TGFA, TGFB1, TGFB2, TGFB3, TGFBR1, TGFBR2, TGFBR3, TSPAN8, WNT3A, WNT5A]	FALSE
WP:2875	WikiPathways_09.11.2015	Constitutive Androstane Receptor Pathway	[-1]	[Group4]	3	9.375	0.01143188197904618	0.5372984530151705	{Group4=0.0018530379237337033}	{Group4=0.02779556885600555}	[ABCB1, CYP2C9, PPP2R4]	[ABCB1, ABCC2, ABCC3, ALAS1, CYP2A6, CYP2B6, CYP2C19, CYP2C9, CYP3A4, CYP3A5, CYP4A11, DNAJC7, EHHADH, FOXO1, GSTA2, HSP90AA1, NCOA1, NCOA2, NCOA6, NR1I3, PPARGC1A, PPP2R4, RXRA, SMC1A, SP1, SULT1A1, SULT2A1, UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9]	FALSE
WP:2916	WikiPathways_09.11.2015	Interactome of polycomb repressive complex 2 (PRC2) 	[-1]	[Group7]	1	6.25	0.21312048940541917	1.0	{Group7=0.2290272399979567}	{Group7=1.0}	[EZH2]	[AEBP2, BCLAF1, EED, ELL, EZH1, EZH2, JARID2, MORC3, MTF2, RBBP4, RBBP7, SETX, STK38, SUZ12, THRAP3, TRIM35]	FALSE
WP:2946	WikiPathways_09.11.2015	Imatinib Resistance in Chronic Myeloid Leukemia	[-1]	[Group8]	4	8.163265	0.005716651368064899	0.2915492197713099	{Group8=0.005716651368064899}	{Group8=0.07431646778484369}	[ABCB1, KIT, PDGFRB, TRIM28]	[ABCB1, ABCG2, ABL1, ANXA2R, BBX, BCL11A, BCR, CASZ1, CCND3, CDK6, CDKN1B, CPEB4, CSF1R, EPO, FLT1, FOXO3, GAB1, GAB2, GADD45A, HMGB2, IGF2BP1, KIT, LYL1, LYN, MAP2K6, MAVS, MYC, NOL4L, NOP2, NSD1, PDGFRA, PDGFRB, PEX14, PIM1, PIM2, PRKACA, PTP4A2, PVT1, RAB36, RPS6KA1, SKP2, SLC4A10, SLC4A7, SLC50A1, SLC7A3, SPRED1, SPRED2, TRIM28, ZC3HAV1]	TRUE
WP:3303	WikiPathways_09.11.2015	Rac1/Pak1/p38/MMP-2 pathway	[-1]	[Group2]	4	6.060606	0.016106467319205318	0.7408974966834446	{Group2=3.192846690077313E-6}	{Group2=5.427839373131432E-5}	[EGFR, HRAS, PIK3CA, TP53]	[AKT1, ANGPT1, ANGPT2, ANGPT4, ANGPTL1, BAD, BAX, BIRC5, CASP7, CASP9, CHUK, CRK, CTNNB1, DOK2, EGFR, EIF4EBP1, ERBB2, FN1, FOXO1, GRB14, GRB2, GRB7, HRAS, IKBKB, ITGB1, KRAS, MAPK1, MAPK11, MAPK12, MAPK13, MAPK14, MAPK3, MAPK8, MAPK9, MSH2, MYC, NCK1, NFKB1, NFKBIA, NOS1, NOS2, NRAS, PAK1, PIK3CA, PIK3R1, PTK2, PTPN11, PXN, RAC1, RAD51, RASA1, RELA, RS1, SOS1, SRC, STAT3, STAT5A, STAT5B, STMN1, TEK, TIE1, TNIP1, TNIP2, TNIP3, TP53, YAP1]	FALSE
